Diego Torres, Medical Doctor

Centro de Educación Médica e Investigaciones Clínicas, CEMIC, Argentina

Disclosure(s): Gador: Honoraria; GSK: Advisor/Consultant; Khight Therapeutics: Honoraria; MSD: Honoraria

Poster(s):

• (P-1481) Short-Treatment with Ceftazidime-Avibactam for Carbapenemase-Producing Enterobacterales Bacteremia
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1482) Ceftazidime-Avibactam for Treating Bacteremic and Non-Bacteremic Carbapenemase-Producing Enterobacterales Infections in Immunocompromised Patients
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1483) Clinical Features and Outcomes of KPC and NDM Carbapenemase-Producing Enterobacterales Infection in the Era of Avibactam
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-2264) Epidemiology and Outcomes of Bacteremia in Neutropenic Patients: A Changing Scenario over Time
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT